Earnings Summary

Treace Medical Concepts Inc’s revenue jumped 40% since last year same period to $41.95Mn in the Q2 2023. On a quarterly growth basis, Treace Medical Concepts Inc has generated -0.57% fall in its revenue since last 3-months.

Treace Medical Concepts Inc’s net profit jumped 28.8% since last year same period to $-12.27Mn in the Q2 2023. On a quarterly growth basis, Treace Medical Concepts Inc has generated 8.79% jump in its net profits since last 3-months.

Treace Medical Concepts Inc’s net profit margin jumped 49.14% since last year same period to -29.25% in the Q2 2023. On a quarterly growth basis, Treace Medical Concepts Inc has generated 8.27% jump in its net profit margins since last 3-months.

Treace Medical Concepts Inc’s earning per share (EPS) estimates for the current quarter stand at -0.14 - a 51.72% jump from last quarter’s estimates.

Treace Medical Concepts Inc’s earning per share (EPS) estimates for the current year stand at -0.14.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Treace Medical Concepts Inc’s return on assets (ROA) stands at -0.13.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Treace Medical Concepts Inc’s return on equity (ROE) stands at -0.38.